The FDA approved Pfizer's maternal vaccine to protect newborns from RSV. Courtesy Pfizer Still, the vaccine, given from 32 to 36 weeks of gestational age, does not provide long-term protection.

CDC Director Mandy Cohen still needs to sign off on that recommendation before mothers can receive Pfizer's shot to protect ...

An independent panel of independent advisers for the Centers for Disease Control and Prevention backed Pfizer's respiratory ...

A panel of advisers recommended the Centers for Disease Control and Prevention add Pfizer Inc.’s RSV vaccine to the list of ...

A key CDC advisory committee Friday voted to recommend infant immunization against RSV via Pfizer's maternal vaccination.

The Food and Drug Administration (FDA) has approved the first vaccine for pregnant women to prevent RSV in infants, the agency announced on Monday. Abrysvo has been approved as a maternal vaccine to ...

One month after the FDA’s initial approval, the CDC voted to recommend Pfizer’s RSV vaccine for pregnant people who are ...

The Food and Drug Administration approved Abrysvo, Pfizer’s respiratory syncytial virus (RSV) vaccine, for use in pregnant individuals to prevent lower respiratory tract disease (LRTD) and severe LRTD ...

PHILADELPHIA (CBS) -- A new weapon to fight a contagious respiratory virus that strikes young children. The first vaccine to protect infants from RSV was just approved by the FDA. It would be ...

The Centers for Disease Control and Prevention recommended on Friday the first maternal RSV vaccine for pregnant people given ...

In a nearly unanimous vote, advisors to the Centers for Disease Control and Prevention have recommended a new vaccine to ...

Advisers to the U.S. Centers for Disease Control and Prevention (CDC) are meeting on Friday to discuss recommendations for ...